APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Drug Delivery Devices Market Outlook and Growth Opportunities 2026

4 July 2026194 pages

Choose your research edition.

Industry ResearchIntravenous Drug Delivery Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Drug Delivery Devices Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Intravenous Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Drug Delivery Devices Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Drug Delivery Devices Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Intravenous Drug Delivery Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intravenous Drug Delivery Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intravenous Drug Delivery Devices market include Johnson & Johnson, Novartis, Pfizer, Teva Pharmaceuticals, Schott, Novo Nordisk, Insulet Corporation, Gerresheimer and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Drug Delivery Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Drug Delivery Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Drug Delivery Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Drug Delivery Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Drug Delivery Devices Segment by Company

Johnson & Johnson

Novartis

Pfizer

Teva Pharmaceuticals

Schott

Novo Nordisk

Insulet Corporation

Gerresheimer

Eli Lilly and Company

Cardinal Health

Becton Dickinson and Company

Baxter International

B. Braun Melsungen AG

Intravenous Drug Delivery Devices Segment by Type

Auto-injectors (Syringe and Cartridge Based)

Pen Injectors

Others

Intravenous Drug Delivery Devices Segment by Application

Home Care

Nursing Homes

Hospitals

Others

Intravenous Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intravenous Drug Delivery Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intravenous Drug Delivery Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Drug Delivery Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Drug Delivery Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Drug Delivery Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Drug Delivery Devices industry.

Chapter 3: Detailed analysis of Intravenous Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intravenous Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intravenous Drug Delivery Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Drug Delivery Devices Industry Trends Table 2. Intravenous Drug Delivery Devices Industry Drivers Table 3. Intravenous Drug Delivery Devices Industry Opportunities and Challenges Table 4. Intravenous Drug Delivery Devices Industry Restraints Table 5. Global Intravenous Drug Delivery Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Drug Delivery Devices Revenue Share by Company (2021-2026) Table 7. Global Intravenous Drug Delivery Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Intravenous Drug Delivery Devices Sales Volume Share by Company (2021-2026) Table 9. Global Intravenous Drug Delivery Devices Average Price (USD/unit) of Company (2021-2026) Table 10. Global Intravenous Drug Delivery Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intravenous Drug Delivery Devices Key Company Manufacturing Base & Headquarters Table 12. Global Intravenous Drug Delivery Devices Company, Product Type & Application Table 13. Global Intravenous Drug Delivery Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Auto-injectors (Syringe and Cartridge Based) Table 18. Significant Companies of Pen Injectors Table 19. Significant Companies of Others Table 20. Global Intravenous Drug Delivery Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Intravenous Drug Delivery Devices Sales Volume by Type (2021-2026) & (k units) Table 22. Global Intravenous Drug Delivery Devices Sales Volume by Type (2027-2032) & (k units) Table 23. Global Intravenous Drug Delivery Devices Sales Volume Share by Type (2021-2026) Table 24. Global Intravenous Drug Delivery Devices Sales Volume Share by Type (2027-2032) Table 25. Global Intravenous Drug Delivery Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Intravenous Drug Delivery Devices Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Intravenous Drug Delivery Devices Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Intravenous Drug Delivery Devices Sales Value Share by Type (2021-2026) Table 29. Global Intravenous Drug Delivery Devices Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Home Care Table 31. Significant Companies of Nursing Homes Table 32. Significant Companies of Hospitals Table 33. Significant Companies of Others Table 34. Global Intravenous Drug Delivery Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Intravenous Drug Delivery Devices Sales Volume by Application (2021-2026) & (k units) Table 36. Global Intravenous Drug Delivery Devices Sales Volume by Application (2027-2032) & (k units) Table 37. Global Intravenous Drug Delivery Devices Sales Volume Share by Application (2021-2026) Table 38. Global Intravenous Drug Delivery Devices Sales Volume Share by Application (2027-2032) Table 39. Global Intravenous Drug Delivery Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Intravenous Drug Delivery Devices Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Intravenous Drug Delivery Devices Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Intravenous Drug Delivery Devices Sales Value Share by Application (2021-2026) Table 43. Global Intravenous Drug Delivery Devices Sales Value Share by Application (2027-2032) Table 44. Global Intravenous Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Intravenous Drug Delivery Devices Sales by Region (2021-2026) & (k units) Table 46. Global Intravenous Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 47. Global Intravenous Drug Delivery Devices Sales by Region (2027-2032) & (k units) Table 48. Global Intravenous Drug Delivery Devices Sales Market Share by Region (2027-2032) Table 49. Global Intravenous Drug Delivery Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Intravenous Drug Delivery Devices Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Intravenous Drug Delivery Devices Sales Value Share by Region (2021-2026) Table 52. Global Intravenous Drug Delivery Devices Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Intravenous Drug Delivery Devices Sales Value Share by Region (2027-2032) Table 54. Global Intravenous Drug Delivery Devices Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Intravenous Drug Delivery Devices Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Intravenous Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Intravenous Drug Delivery Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Intravenous Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 59. Global Intravenous Drug Delivery Devices Sales Market Share by Country (2021-2026) Table 60. Global Intravenous Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 61. Global Intravenous Drug Delivery Devices Sales Market Share by Country (2027-2032) Table 62. Global Intravenous Drug Delivery Devices Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Intravenous Drug Delivery Devices Sales Value Market Share by Country (2021-2026) Table 64. Global Intravenous Drug Delivery Devices Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Intravenous Drug Delivery Devices Sales Value Market Share by Country (2027-2032) Table 66. Johnson & Johnson Company Information Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Johnson & Johnson Intravenous Drug Delivery Devices Product Portfolio Table 70. Johnson & Johnson Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Novartis Intravenous Drug Delivery Devices Product Portfolio Table 75. Novartis Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Pfizer Intravenous Drug Delivery Devices Product Portfolio Table 80. Pfizer Recent Development Table 81. Teva Pharmaceuticals Company Information Table 82. Teva Pharmaceuticals Business Overview Table 83. Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Portfolio Table 85. Teva Pharmaceuticals Recent Development Table 86. Schott Company Information Table 87. Schott Business Overview Table 88. Schott Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Schott Intravenous Drug Delivery Devices Product Portfolio Table 90. Schott Recent Development Table 91. Novo Nordisk Company Information Table 92. Novo Nordisk Business Overview Table 93. Novo Nordisk Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Novo Nordisk Intravenous Drug Delivery Devices Product Portfolio Table 95. Novo Nordisk Recent Development Table 96. Insulet Corporation Company Information Table 97. Insulet Corporation Business Overview Table 98. Insulet Corporation Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Insulet Corporation Intravenous Drug Delivery Devices Product Portfolio Table 100. Insulet Corporation Recent Development Table 101. Gerresheimer Company Information Table 102. Gerresheimer Business Overview Table 103. Gerresheimer Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Gerresheimer Intravenous Drug Delivery Devices Product Portfolio Table 105. Gerresheimer Recent Development Table 106. Eli Lilly and Company Company Information Table 107. Eli Lilly and Company Business Overview Table 108. Eli Lilly and Company Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Eli Lilly and Company Intravenous Drug Delivery Devices Product Portfolio Table 110. Eli Lilly and Company Recent Development Table 111. Cardinal Health Company Information Table 112. Cardinal Health Business Overview Table 113. Cardinal Health Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Cardinal Health Intravenous Drug Delivery Devices Product Portfolio Table 115. Cardinal Health Recent Development Table 116. Becton Dickinson and Company Company Information Table 117. Becton Dickinson and Company Business Overview Table 118. Becton Dickinson and Company Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Becton Dickinson and Company Intravenous Drug Delivery Devices Product Portfolio Table 120. Becton Dickinson and Company Recent Development Table 121. Baxter International Company Information Table 122. Baxter International Business Overview Table 123. Baxter International Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Baxter International Intravenous Drug Delivery Devices Product Portfolio Table 125. Baxter International Recent Development Table 126. B. Braun Melsungen AG Company Information Table 127. B. Braun Melsungen AG Business Overview Table 128. B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Portfolio Table 130. B. Braun Melsungen AG Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Intravenous Drug Delivery Devices Distributors List Table 134. Intravenous Drug Delivery Devices Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Intravenous Drug Delivery Devices Product Image Figure 2. Global Intravenous Drug Delivery Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intravenous Drug Delivery Devices Sales (2021-2032) & (k units) Figure 5. Global Intravenous Drug Delivery Devices Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Intravenous Drug Delivery Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Auto-injectors (Syringe and Cartridge Based) Image Figure 10. Pen Injectors Image Figure 11. Others Image Figure 12. Global Intravenous Drug Delivery Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Intravenous Drug Delivery Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Intravenous Drug Delivery Devices Sales Volume Share by Type (2021-2032) Figure 15. Global Intravenous Drug Delivery Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Intravenous Drug Delivery Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Intravenous Drug Delivery Devices Sales Value Share by Type (2021-2032) Figure 18. Home Care Image Figure 19. Nursing Homes Image Figure 20. Hospitals Image Figure 21. Others Image Figure 22. Global Intravenous Drug Delivery Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Intravenous Drug Delivery Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Intravenous Drug Delivery Devices Sales Volume Share by Application (2021-2032) Figure 25. Global Intravenous Drug Delivery Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Intravenous Drug Delivery Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Intravenous Drug Delivery Devices Sales Value Share by Application (2021-2032) Figure 28. Global Intravenous Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Intravenous Drug Delivery Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Intravenous Drug Delivery Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Intravenous Drug Delivery Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Intravenous Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 33. North America Intravenous Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Intravenous Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Intravenous Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Intravenous Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Intravenous Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Intravenous Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 39. South America Intravenous Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Intravenous Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Intravenous Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Intravenous Drug Delivery Devices Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Intravenous Drug Delivery Devices Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Auto-injectors (Syringe and Cartridge Based)
  • Pen Injectors
  • Others
Applications
  • Home Care
  • Nursing Homes
  • Hospitals
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Teva Pharmaceuticals
  • Schott
  • Novo Nordisk
  • Insulet Corporation
  • Gerresheimer
  • Eli Lilly and Company
  • Cardinal Health
  • Becton Dickinson and Company
  • Baxter International
  • B. Braun Melsungen AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Drug Delivery Devices Sales Value (2021-2032)
  4. 1.2.2 Global Intravenous Drug Delivery Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Intravenous Drug Delivery Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intravenous Drug Delivery Devices Market Dynamics
  1. 2.1 Intravenous Drug Delivery Devices Industry Trends
  2. 2.2 Intravenous Drug Delivery Devices Industry Drivers
  3. 2.3 Intravenous Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Intravenous Drug Delivery Devices Industry Restraints
3 Intravenous Drug Delivery Devices Market by Company
  1. 3.1 Global Intravenous Drug Delivery Devices Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Drug Delivery Devices Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Drug Delivery Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Intravenous Drug Delivery Devices Average Price by Company (2021-2026)
  5. 3.5 Global Intravenous Drug Delivery Devices Company Ranking (2024-2026)
  6. 3.6 Global Intravenous Drug Delivery Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Intravenous Drug Delivery Devices Company Product Type and Application
  8. 3.8 Global Intravenous Drug Delivery Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intravenous Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intravenous Drug Delivery Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intravenous Drug Delivery Devices Market by Type
  1. 4.1 Intravenous Drug Delivery Devices Type Introduction
  2. 4.1.1 Auto-injectors (Syringe and Cartridge Based)
  3. 4.1.2 Pen Injectors
  4. 4.1.3 Others
  5. 4.2 Global Intravenous Drug Delivery Devices Sales Volume by Type
  6. 4.2.1 Global Intravenous Drug Delivery Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Intravenous Drug Delivery Devices Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Intravenous Drug Delivery Devices Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Intravenous Drug Delivery Devices Sales Value by Type
  10. 4.3.1 Global Intravenous Drug Delivery Devices Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Intravenous Drug Delivery Devices Sales Value by Type (2021-2032)
  12. 4.3.3 Global Intravenous Drug Delivery Devices Sales Value Share by Type (2021-2032)
5 Intravenous Drug Delivery Devices Market by Application
  1. 5.1 Intravenous Drug Delivery Devices Application Introduction
  2. 5.1.1 Home Care
  3. 5.1.2 Nursing Homes
  4. 5.1.3 Hospitals
  5. 5.1.4 Others
  6. 5.2 Global Intravenous Drug Delivery Devices Sales Volume by Application
  7. 5.2.1 Global Intravenous Drug Delivery Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Intravenous Drug Delivery Devices Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Intravenous Drug Delivery Devices Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Intravenous Drug Delivery Devices Sales Value by Application
  11. 5.3.1 Global Intravenous Drug Delivery Devices Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Intravenous Drug Delivery Devices Sales Value by Application (2021-2032)
  13. 5.3.3 Global Intravenous Drug Delivery Devices Sales Value Share by Application (2021-2032)
6 Intravenous Drug Delivery Devices Regional Sales and Value Analysis
  1. 6.1 Global Intravenous Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Drug Delivery Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Drug Delivery Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Intravenous Drug Delivery Devices Sales by Region (2027-2032)
  5. 6.3 Global Intravenous Drug Delivery Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intravenous Drug Delivery Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intravenous Drug Delivery Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intravenous Drug Delivery Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Intravenous Drug Delivery Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intravenous Drug Delivery Devices Sales Value (2021-2032)
  12. 6.6.2 North America Intravenous Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intravenous Drug Delivery Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Intravenous Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intravenous Drug Delivery Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intravenous Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intravenous Drug Delivery Devices Sales Value (2021-2032)
  21. 6.9.2 South America Intravenous Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intravenous Drug Delivery Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intravenous Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
7 Intravenous Drug Delivery Devices Country-level Sales and Value Analysis
  1. 7.1 Global Intravenous Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Drug Delivery Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intravenous Drug Delivery Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Intravenous Drug Delivery Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Intravenous Drug Delivery Devices Sales by Country (2027-2032)
  6. 7.4 Global Intravenous Drug Delivery Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intravenous Drug Delivery Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intravenous Drug Delivery Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intravenous Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intravenous Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intravenous Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Intravenous Drug Delivery Devices Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Intravenous Drug Delivery Devices Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Intravenous Drug Delivery Devices Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Teva Pharmaceuticals
  20. 8.4.1 Teva Pharmaceuticals Company Information
  21. 8.4.2 Teva Pharmaceuticals Business Overview
  22. 8.4.3 Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Portfolio
  24. 8.4.5 Teva Pharmaceuticals Recent Developments
  25. 8.5 Schott
  26. 8.5.1 Schott Company Information
  27. 8.5.2 Schott Business Overview
  28. 8.5.3 Schott Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Schott Intravenous Drug Delivery Devices Product Portfolio
  30. 8.5.5 Schott Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk Intravenous Drug Delivery Devices Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 Insulet Corporation
  38. 8.7.1 Insulet Corporation Company Information
  39. 8.7.2 Insulet Corporation Business Overview
  40. 8.7.3 Insulet Corporation Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Insulet Corporation Intravenous Drug Delivery Devices Product Portfolio
  42. 8.7.5 Insulet Corporation Recent Developments
  43. 8.8 Gerresheimer
  44. 8.8.1 Gerresheimer Company Information
  45. 8.8.2 Gerresheimer Business Overview
  46. 8.8.3 Gerresheimer Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gerresheimer Intravenous Drug Delivery Devices Product Portfolio
  48. 8.8.5 Gerresheimer Recent Developments
  49. 8.9 Eli Lilly and Company
  50. 8.9.1 Eli Lilly and Company Company Information
  51. 8.9.2 Eli Lilly and Company Business Overview
  52. 8.9.3 Eli Lilly and Company Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Eli Lilly and Company Intravenous Drug Delivery Devices Product Portfolio
  54. 8.9.5 Eli Lilly and Company Recent Developments
  55. 8.10 Cardinal Health
  56. 8.10.1 Cardinal Health Company Information
  57. 8.10.2 Cardinal Health Business Overview
  58. 8.10.3 Cardinal Health Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cardinal Health Intravenous Drug Delivery Devices Product Portfolio
  60. 8.10.5 Cardinal Health Recent Developments
  61. 8.11 Becton Dickinson and Company
  62. 8.11.1 Becton Dickinson and Company Company Information
  63. 8.11.2 Becton Dickinson and Company Business Overview
  64. 8.11.3 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Becton Dickinson and Company Intravenous Drug Delivery Devices Product Portfolio
  66. 8.11.5 Becton Dickinson and Company Recent Developments
  67. 8.12 Baxter International
  68. 8.12.1 Baxter International Company Information
  69. 8.12.2 Baxter International Business Overview
  70. 8.12.3 Baxter International Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Baxter International Intravenous Drug Delivery Devices Product Portfolio
  72. 8.12.5 Baxter International Recent Developments
  73. 8.13 B. Braun Melsungen AG
  74. 8.13.1 B. Braun Melsungen AG Company Information
  75. 8.13.2 B. Braun Melsungen AG Business Overview
  76. 8.13.3 B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Portfolio
  78. 8.13.5 B. Braun Melsungen AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Drug Delivery Devices Value Chain Analysis
  2. 9.1.1 Intravenous Drug Delivery Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Drug Delivery Devices Sales Mode & Process
  6. 9.2 Intravenous Drug Delivery Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Drug Delivery Devices Distributors
  9. 9.2.3 Intravenous Drug Delivery Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst